A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351

Clinical trial NCT03555955 · COMPLETED

Trial details

NCT number: NCT03555955
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy Acute Myeloid Leukemia Acute Lymphocytic Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes

Start date: 2018-11-20
Primary completion: 2021-05-26
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.